RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis	Neoplasms by Site, Paraneoplastic Syndromes, Nervous System, autoimmune disease, autoimmune disorder of the nervous system, immune system disorder, myasthenia gravis, neoplasm, nervous system disorder, neurodegenerative disease, neuromuscular disease, neuromuscular junction disease, paraneoplastic syndrome	Recruiting	Phase 1 / Phase 2	2026-10-09		NCT06359041

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Cabaletta Bio	5

17 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Baylor College of Medicine Neurology Department	Houston	United States	1
Beth Israel Deaconess Medical Center	Boston	United States	462
Columbia University	New York	United States	154
Houston Methodist Hospital	Houston	United States	260
Mayo Clinic - Rochester	Rochester	United States	59
Mayo Clinic Florida	Jacksonville	United States	105
Northwestern Memorial Hospital	Chicago	United States	129
Oregon Health & Science University	Portland	United States	261
Swedish Neuroscience Research	Seattle	United States	2
UC Davis, Department of Neurology	Sacramento	United States	1
University of California Irvine	Orange	United States	49
University of California, San Francisco	San Francisco	United States	294
University of Colorado	Aurora	United States	147
University of Kansas Medical Center	Kansas City	United States	240
University of Massachusetts Chan Medical School	Worcester	United States	33
University of Rochester Medical Center	Rochester	United States	162
University of Texas MD Anderson Cancer Center	Houston	United States	192